Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03000452

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • Cancer Center of Central Connecticut Southington, Connecticut, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
View all 25 locations
View Trial Details
Completed

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

NCT01636687

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Anatomical, +11 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Oceanside, California, United States
  • Novartis Investigative Site Overland Park, Kansas, United States
View all 39 locations
View Trial Details
Completed

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

NCT01319864

Conditions
ALL, AML, Acute Leukemia of Ambiguous Lineage, +20 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Children's Hospital of Denver Denver, Colorado, United States
  • Children's Healthcare of Atlanta/Emory University Atlanta, Georgia, United States
  • Johns Hopkins Medical Center Baltimore, Maryland, United States
View Trial Details

Related conditions